DE122012000017I1 - Neuartige form von s-omeprazol. - Google Patents

Neuartige form von s-omeprazol.

Info

Publication number
DE122012000017I1
DE122012000017I1 DE201212000017 DE122012000017C DE122012000017I1 DE 122012000017 I1 DE122012000017 I1 DE 122012000017I1 DE 201212000017 DE201212000017 DE 201212000017 DE 122012000017 C DE122012000017 C DE 122012000017C DE 122012000017 I1 DE122012000017 I1 DE 122012000017I1
Authority
DE
Germany
Prior art keywords
omeprazole
novel form
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE201212000017
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122012000017(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE122012000017I1 publication Critical patent/DE122012000017I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE201212000017 1997-05-30 2012-03-26 Neuartige form von s-omeprazol. Pending DE122012000017I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702065A SE510650C2 (sv) 1997-05-30 1997-05-30 Ny förening
PCT/SE1998/000974 WO1998054171A1 (en) 1997-05-30 1998-05-25 Novel form of s-omeprazole

Publications (1)

Publication Number Publication Date
DE122012000017I1 true DE122012000017I1 (de) 2012-08-16

Family

ID=20407186

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69829511T Expired - Lifetime DE69829511T2 (de) 1997-05-30 1998-05-25 Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat
DE69814069.9T Expired - Lifetime DE69814069T3 (de) 1997-05-30 1998-05-25 Neuartige form von s-omeprazol
DE201212000017 Pending DE122012000017I1 (de) 1997-05-30 2012-03-26 Neuartige form von s-omeprazol.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69829511T Expired - Lifetime DE69829511T2 (de) 1997-05-30 1998-05-25 Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat
DE69814069.9T Expired - Lifetime DE69814069T3 (de) 1997-05-30 1998-05-25 Neuartige form von s-omeprazol

Country Status (44)

Country Link
US (6) US6369085B1 (de)
EP (2) EP1273581B1 (de)
JP (2) JP4002303B2 (de)
KR (2) KR100540720B1 (de)
CN (1) CN1161351C (de)
AR (2) AR012717A1 (de)
AT (2) ATE239011T1 (de)
AU (1) AU722839B2 (de)
BR (1) BR9809509A (de)
CA (2) CA2290963C (de)
CY (1) CY2012029I2 (de)
CZ (1) CZ297585B6 (de)
DE (3) DE69829511T2 (de)
DK (2) DK1273581T3 (de)
DZ (1) DZ2495A1 (de)
EE (1) EE03875B1 (de)
EG (1) EG24291A (de)
ES (2) ES2195345T7 (de)
HK (2) HK1025962A1 (de)
HR (1) HRP980263B1 (de)
HU (1) HU225987B1 (de)
ID (1) ID29306A (de)
IL (1) IL132947A0 (de)
IS (2) IS2142B (de)
LU (2) LU91871I2 (de)
MA (1) MA26500A1 (de)
ME (3) MEP18008A (de)
MY (2) MY127793A (de)
NO (3) NO317518B1 (de)
NZ (1) NZ500991A (de)
PL (1) PL193546B1 (de)
PT (2) PT984957E (de)
RS (2) RS50067B (de)
RU (1) RU2184115C2 (de)
SA (2) SA05260296B1 (de)
SE (1) SE510650C2 (de)
SI (2) SI0984957T1 (de)
SK (2) SK285137B6 (de)
TN (1) TNSN98074A1 (de)
TR (1) TR199902934T2 (de)
TW (1) TW538040B (de)
UA (1) UA60334C2 (de)
WO (1) WO1998054171A1 (de)
ZA (1) ZA984179B (de)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DK0909323T3 (da) 1996-01-04 2007-05-21 Novartis Vaccines & Diagnostic Helicobacter pylori-bakterioferritin
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2474246C (en) 2002-03-05 2010-06-29 Astrazeneca Ab Alkylammonium salts of omeprazole and esomeprazole
AU2003262375A1 (en) * 2002-04-22 2003-11-03 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
CA2491118A1 (en) * 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
WO2004002982A2 (en) * 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
EP2596792A1 (de) * 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stabile, feste Präparate
US20040235903A1 (en) * 2002-10-22 2004-11-25 Khanna Mahavir Singh Amorphous form of esomeprazole salts
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
WO2004060263A2 (en) * 2003-01-07 2004-07-22 Ranbaxy Laboratories Limited Magnesium salt of imidazole derivative
AU2003238671A1 (en) * 2003-04-10 2004-11-01 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
WO2004099181A1 (en) 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR046400A1 (es) * 2003-07-23 2005-12-07 Altana Pharma Ag Sales de pantoprazol
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
MXPA06011820A (es) * 2004-04-16 2006-12-15 Santarus Inc Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico.
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
US20050267157A1 (en) * 2004-05-28 2005-12-01 David White Magnesium-S-omeprazole
WO2006009602A2 (en) 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
CN1972928A (zh) * 2004-06-24 2007-05-30 阿斯利康(瑞典)有限公司 制备用于制备依美拉唑钠盐的结晶修饰物的新方法
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
US20060210637A1 (en) * 2005-03-17 2006-09-21 Qpharma, Llc Stable tablet dosage forms of proton pump inhibitors
KR20080007508A (ko) * 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물
US7563812B2 (en) 2005-06-15 2009-07-21 Hetero Drugs Limited Amorphous esomeprazole hydrate
EP1904064A4 (de) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr Omeprazol form b
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
WO2007031845A2 (en) * 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
EP1934201A1 (de) * 2005-10-06 2008-06-25 Auspex Pharmaceuticals Inc. Deuterierte hemmer von gastrischer h+, k+-atpase mit verstärkten therapeutischen eigenschaften
CA2626085C (en) * 2005-10-26 2011-12-06 Hanmi Pharm. Co., Ltd. S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
US7576219B2 (en) * 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (de) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Argininsalz des Esomeprazols
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
CN100384839C (zh) * 2006-02-17 2008-04-30 中国科学院上海有机化学研究所 [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8063074B2 (en) 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
EP2040710A2 (de) * 2006-06-21 2009-04-01 Glenmark Pharmaceuticals Limited Neuer polymorph von esomeprazol-kalium und verfahren zu seiner herstellung
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
EP1947099A1 (de) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
EP2114919A2 (de) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von optisch reinem omeprazol durch salzbildung mit einem chiralen amin oder behandlung mit einem enantiomer umwandelnden enzym und chromatographische auftrennung
WO2008102145A2 (en) * 2007-02-21 2008-08-28 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
KR101303813B1 (ko) * 2007-04-16 2013-09-04 에스케이케미칼주식회사 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
EP2000468A1 (de) 2007-05-09 2008-12-10 Dr. Reddy's Laboratories Ltd. Esomeprazolsalze und Verfahren zur Herstellung davon
ATE534643T1 (de) * 2007-06-07 2011-12-15 Aurobindo Pharma Ltd Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
AU2008310735B2 (en) 2007-10-12 2013-09-12 Takeda Pharmaceutical Company Limited Methods of treating gastrointestinal disorders independent of the intake of food
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
EP2240496A4 (de) * 2008-02-01 2011-05-11 Reddys Lab Ltd Dr Herstellung von esomeprazol-magnesium und hydraten davon
WO2009137648A1 (en) * 2008-05-09 2009-11-12 Aptapharma, Inc. Multilayer proton pump inhibitor tablets
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2143722A1 (de) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium
EP2147918A1 (de) * 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CN101391993B (zh) * 2008-10-28 2012-07-04 安徽美诺华药物化学有限公司 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20100267959A1 (en) * 2009-04-15 2010-10-21 Glenmark Generics Limited Process for the preparation of esomeprazole magnesium dihydrate
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
WO2010150276A2 (en) * 2009-06-02 2010-12-29 Sun Pharmaceutical Industries Limited Process for preparing sulphoxide compounds
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
WO2010151697A1 (en) * 2009-06-25 2010-12-29 Pozen Inc. Method for treating a patient in need of aspirin therapy
WO2011012957A1 (en) * 2009-07-29 2011-02-03 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of esomeprazole magnesium dihydrate
WO2011058569A1 (en) 2009-11-12 2011-05-19 Hetero Research Foundation Process for the resolution of omeprazole
WO2011071982A2 (en) 2009-12-08 2011-06-16 Codexis, Inc. Synthesis of prazole compounds
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
FR2959509B1 (fr) 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CN102241668B (zh) * 2010-05-11 2015-11-25 中国科学院成都有机化学有限公司 S-奥美拉唑盐
WO2012078800A2 (en) 2010-12-08 2012-06-14 Codexis, Inc. Biocatalysts and methods for the synthesis of armodafinil
CN102757421A (zh) * 2011-04-29 2012-10-31 江苏正大天晴药业股份有限公司 埃索美拉唑的纯化方法
CN104844577A (zh) * 2011-07-31 2015-08-19 连云港润众制药有限公司 埃索美拉唑镁的晶型
CN102936238B (zh) * 2011-11-25 2015-02-18 成都自豪药业有限公司 S-奥美拉唑镁盐的晶型及其制备方法
WO2013088272A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Pharmaceutical composition comprising esomeprazole magnesium dihydrate
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
CN102584792B (zh) * 2012-01-06 2014-06-11 南京优科生物医药研究有限公司 制备高纯度的埃索美拉唑盐的方法
CN102993184A (zh) * 2013-01-08 2013-03-27 湖南方盛制药股份有限公司 一种埃索美拉唑及其镁盐三水合物的制备方法
CN104250243B (zh) * 2013-06-27 2016-12-28 四川国为制药有限公司 一种埃索美拉唑镁二水合物a晶型的制备方法
CN103570686B (zh) * 2013-10-14 2015-04-01 哈药集团技术中心 一种埃索美拉唑钠的合成及精制工艺
CN104725357A (zh) * 2013-12-24 2015-06-24 苏州联友制药技术有限公司 一种埃索美拉唑镁二水合物晶型b的制备方法
FR3018812A1 (fr) * 2014-03-21 2015-09-25 Minakem Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
CN104447699A (zh) * 2014-12-10 2015-03-25 哈药集团技术中心 一种埃索美拉唑镁三水合物的制备方法
CN105111188B (zh) * 2015-08-19 2018-01-19 扬子江药业集团有限公司 一种埃索美拉唑镁三水合物晶型的制备方法
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
CN106397402B (zh) * 2016-08-30 2019-05-03 山东罗欣药业集团股份有限公司 一种埃索美拉唑镁晶型化合物及其制备方法
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
KR102432084B1 (ko) 2021-11-16 2022-08-12 알리코제약(주) S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
US5244891A (en) 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5360582A (en) 1991-07-15 1994-11-01 Minnesota Mining And Manufacturing Company Nonlinear optical materials containing polar disulfone-functionalized molecules
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
FR2719045B1 (fr) * 1994-04-20 1996-05-31 Rhone Poulenc Chimie Procédé de préparation d'acide L-aspartique à partir d'aspartate d'ammonium.
FR2722191B1 (fr) 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
MX9600857A (es) 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US5948913A (en) 1994-11-14 1999-09-07 Daiichi Pharmaceutical Co., Ltd. Hydrate for drug use
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
SE9500422D0 (sv) 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
CN1042423C (zh) 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
AR057181A1 (es) 2005-11-30 2007-11-21 Astra Ab Nueva forma de dosificacion de combinacion

Also Published As

Publication number Publication date
ME00198B (me) 2011-02-10
ZA984179B (en) 1998-11-30
PL337180A1 (en) 2000-08-14
WO1998054171A1 (en) 1998-12-03
EP1273581B1 (de) 2005-03-23
UA60334C2 (uk) 2003-10-15
ES2195345T3 (es) 2003-12-01
TW538040B (en) 2003-06-21
TNSN98074A1 (fr) 2005-03-15
SE9702065D0 (sv) 1997-05-30
KR100540720B1 (ko) 2006-01-12
MY120745A (en) 2005-11-30
SE9702065L (sv) 1998-12-01
RU2184115C2 (ru) 2002-06-27
ATE291574T1 (de) 2005-04-15
LU92017I2 (fr) 2012-08-06
SK162599A3 (en) 2000-06-12
CA2290963A1 (en) 1998-12-03
DE69829511D1 (de) 2005-04-28
SA98190280B1 (ar) 2006-07-04
DK0984957T3 (da) 2003-06-30
EE03875B1 (et) 2002-10-15
US8076361B2 (en) 2011-12-13
TR199902934T2 (xx) 2000-04-21
US7745466B2 (en) 2010-06-29
SE510650C2 (sv) 1999-06-14
MEP18008A (en) 2010-10-10
EP0984957A1 (de) 2000-03-15
AR059589A2 (es) 2008-04-16
LU91871I2 (fr) 2011-11-21
EP0984957B3 (de) 2013-09-18
DE69814069T3 (de) 2014-03-27
US20050075369A1 (en) 2005-04-07
US6369085B1 (en) 2002-04-09
PL193546B1 (pl) 2007-02-28
YU60999A (sh) 2002-03-18
US6677455B2 (en) 2004-01-13
CA2521391C (en) 2009-09-29
SK284837B6 (sk) 2005-12-01
BR9809509A (pt) 2000-06-20
MY127793A (en) 2006-12-29
US7411070B2 (en) 2008-08-12
DE69814069T2 (de) 2004-04-01
MA26500A1 (fr) 2004-12-20
HRP980263B1 (en) 2002-02-28
CY2012029I1 (el) 2015-08-05
PT1273581E (pt) 2005-06-30
HUP0001849A2 (hu) 2002-05-29
CZ297585B6 (cs) 2007-01-10
IS2142B (is) 2006-09-15
ES2195345T7 (es) 2014-01-15
PT984957E (pt) 2003-07-31
CN1258295A (zh) 2000-06-28
RS50067B (sr) 2009-01-22
DK1273581T3 (da) 2005-06-06
NZ500991A (en) 2001-05-25
CA2290963C (en) 2006-03-28
EP1273581A1 (de) 2003-01-08
JP2002501529A (ja) 2002-01-15
KR20010013126A (ko) 2001-02-26
IS2774B (is) 2012-03-15
KR100527804B1 (ko) 2005-11-15
DZ2495A1 (fr) 2003-01-25
RS50005B (sr) 2008-09-29
AU722839B2 (en) 2000-08-10
NO2011010I1 (no) 2011-06-20
SI1273581T1 (de) 2005-08-31
SK285137B6 (sk) 2006-07-07
ID29306A (id) 2001-08-16
WO1998054171A8 (en) 1999-12-23
US20020198239A1 (en) 2002-12-26
HU225987B1 (en) 2008-02-28
ES2236407T3 (es) 2005-07-16
EP0984957B1 (de) 2003-05-02
MEP24908A (en) 2010-10-10
NO995852L (no) 2000-01-31
CY2012029I2 (el) 2015-08-05
EG24291A (en) 2009-01-08
IS8368A (is) 2006-03-22
AR012717A1 (es) 2000-11-08
US20120252847A1 (en) 2012-10-04
ATE239011T1 (de) 2003-05-15
NO2012011I1 (no) 2012-06-18
US20080255363A1 (en) 2008-10-16
HU0001849D0 (de) 2002-05-29
SI0984957T1 (en) 2003-10-31
KR20050042827A (ko) 2005-05-10
HK1051681A1 (en) 2003-08-15
US20110130570A1 (en) 2011-06-02
CN1161351C (zh) 2004-08-11
DE69829511T2 (de) 2006-02-16
NO995852D0 (no) 1999-11-29
HUP0001849A3 (en) 2003-02-28
JP2007161734A (ja) 2007-06-28
HRP980263A2 (en) 1999-02-28
AU7793598A (en) 1998-12-30
US8466175B2 (en) 2013-06-18
JP4002303B2 (ja) 2007-10-31
SA05260296B1 (ar) 2008-04-16
HK1025962A1 (en) 2000-12-01
IS5272A (is) 1999-11-25
DE69814069D1 (de) 2003-06-05
IL132947A0 (en) 2001-03-19
CA2521391A1 (en) 1998-12-03
EE9900550A (et) 2000-06-15
RS20070459A (en) 2008-06-05
NO317518B1 (no) 2004-11-08

Similar Documents

Publication Publication Date Title
DE122012000017I1 (de) Neuartige form von s-omeprazol.
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69837906D1 (de) Insektizides proteintoxin von xenorhabus
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
MX212055B (es) Microemulsion.
EE03903B1 (et) Omeprasooli ravimvorm
DE19882124T1 (de) Direkte Abscheidung von Gold
ATE259825T1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
PT964867E (pt) Antagonistas da taquicinima
MA24551A1 (fr) W.c.
NO20002555D0 (no) Skjøt
ES1036909Y (es) Pupitre infantil.
FI972138A0 (fi) Returtraog i bestrykningsanordning
ES1037395Y (es) Tendedero antilluvia.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
DE29710141U1 (de) Aufhängevorrichtung von Schürzen
ITPR970022V0 (it) Profilorete asimmetrico.
ES1036948Y (es) Carpeta-atril mejorada.
ES1038416Y (es) Gregadero mejorado.
ES1036324Y (es) Cose-papeles mejorado.
KR970021293U (ko) 특허 출원서 행정 양식
DE29720614U1 (de) Begrenzungen von Ställen
ES1038270Y (es) Anillo-grafo.
ES1037763Y (es) Iluminaria.
ES1036999Y (es) Abonadora-sembradora.